The S&P 500 index closed above 1,800 for the first time. The Dow also made a new high today, indicating a very bullish stock market.
The biggest gainer today was the biotechnology sector. The Fidelity Select Biotechnology Fund (FBIOX) was up 3.15% and continues to be the best performer of 2013 with an incredible 60.05% year-to-date gain. FBIOX shows a highly bullish chart pattern, since it broke through the blue resistance line.
We have followed the greatest bull market of 2012 in the biotech sector throughout the year. The bullish uptrend of the Fidelity Select Biotechnology Fund (FBIOX, last change: 0.24%) currently shows no signs of slowing down. FBIOX is by far the best year-to-date performer of all Fidelity mutual funds with an amazing 42.17% gain.
We have highlighted the Fidelity Select Biotechnology Fund (FBIOX, last change: -0.01%) as one of the top investment choices throughout the year. FBIOX continues to be the best year-to-date performer with 29.12% gain.